01332.HK
Touyun Biotech Group Limited
HKSE · Consumer Cyclical · Packaging & Containers · HK
HKD 0.16
−0.63%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 188.1M | 67.0M | 160.0M | 198.6M | 315.8M |
| Cost of Revenue | 123.0M | 50.8M | 87.9M | 142.0M | 195.7M |
| Gross Profit | 65.1M | 16.2M | 72.1M | 56.6M | 120.1M |
| Operating Expenses | |||||
| R&D Expense | 20.9M | — | 20.9M | 22.3M | 20.3M |
| SG&A Expense | 158.0M | 76.4M | 115.9M | 124.6M | 142.3M |
| General & Admin Expense | 110.0M | 67.9M | 100.5M | 118.0M | 128.2M |
| Selling & Marketing Expense | 15.5M | 8.7M | 15.4M | 23.7M | 26.4M |
| Other Expenses | 1.4M | — | (18.0M) | — | — |
| Total Operating Expenses | 180.3M | 76.4M | 118.8M | 146.9M | 162.6M |
| Cost and Expenses | 303.2M | 127.1M | 227.5M | 289.0M | 358.3M |
| Operating Income (EBIT) | (115.2M) | (60.1M) | (67.6M) | (90.3M) | (42.5M) |
| Non-Operating | |||||
| Interest Income | 144.0K | 21.0K | 80.0K | 140.0K | 85.0K |
| Interest Expense | 42.1M | 21.2M | 10.1M | 7.4M | 21.7M |
| Net Interest Income | (42.0M) | (21.2M) | (10.0M) | (7.3M) | (21.6M) |
| Other Non-Op Income/Expense | 434.3M | 107.7M | (20.8M) | (182.3M) | (156.7M) |
| Non-Operating Income (excl Interest) | (20.9M) | — | (20.9M) | 174.8M | 137.8M |
| EBT (Pre-Tax Income) | 319.2M | 47.6M | (88.4M) | (272.6M) | (199.2M) |
| Income Tax Expense | 29.0K | 11.0K | (326.0K) | (16.0K) | 3.5M |
| Bottom Line | |||||
| Net Income | 184.5M | 26.8M | (88.1M) | (268.9M) | (198.1M) |
| Earnings from Cont. Ops | 319.1M | 47.6M | (88.0M) | (272.6M) | (202.7M) |
| Earnings from Discont. Ops | 15.2M | 13.7M | — | — | — |
| Bottom Line Net Income | 169.3M | 13.1M | (88.1M) | (268.9M) | (198.1M) |
| Per Share | |||||
| Basic EPS | HK$0.06 | HK$0.00 | (HK$0.03) | (HK$0.10) | (HK$0.07) |
| Diluted EPS | HK$0.06 | HK$0.00 | (HK$0.03) | (HK$0.10) | (HK$0.07) |
| Revenue Per Share | HK$0.07 | HK$0.02 | HK$0.06 | HK$0.07 | HK$0.11 |
| Shares | |||||
| Basic Shares Outstanding | 2.8B | 2.8B | 2.8B | 2.8B | 2.8B |
| Diluted Shares Outstanding | 2.8B | 2.8B | 2.8B | 2.8B | 2.8B |
| Profitability Metrics | |||||
| EBITDA | (60.6M) | (47.9M) | (27.9M) | (228.6M) | (144.4M) |
| D&A | 33.6M | 12.3M | 18.7M | 36.6M | 33.1M |
| EBIT | (94.2M) | (60.1M) | (46.7M) | (265.2M) | (177.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026